645
Views
61
CrossRef citations to date
0
Altmetric
Review Articles

Spectroscopic findings in attention-deficit/hyperactivity disorder: Review and meta-analysis

, MD, , , , , , , MD, , , & show all
Pages 355-365 | Received 16 Nov 2007, Published online: 08 Dec 2009

References

  • Aylward EH, Reiss AL, Reader MJ, Singer HS, Brown JE, Denckla MB. Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 1996; 11: 112–115
  • Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001; 45: 765–769
  • Bedard AC, Martinussen R, Ickowicz A, Tannock R. Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2004; 43: 260–268
  • Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237–248
  • Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000; 157: 816–818
  • Brown TR. Practical applications of chemical shift imaging. NMR Biomed 1992; 5: 238–243
  • Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry 2005; 57: 1273–1284
  • Carlsson, A, Hansson, LO, Waters, N, Carlsson, ML. 1999a. A glutamatergic deficiency model of schizophrenia. Br J Psychiatry. Suppl 2–6.
  • Carlsson A, Waters N, Carlsson ML. Neurotransmitter interactions in schizophrenia – therapeutic implications. Biol Psychiatry 1999b; 46: 1388–1395
  • Carrey N, MacMaster FP, Sparkes SJ, Khan SC, Kusumakar V. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. J Child Adolesc Psychopharmacol 2002; 12: 331–336
  • Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S, et al. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clin Neuropharmacol 2003; 26: 218–221
  • Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007; 17: 11–17
  • Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53: 607–616
  • Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. J Am Med Assoc 2002; 288: 1740–1748
  • Colla M, Ende G, Alm B, Deuschle M, Heuser I, Kronenberg G. Cognitive MR spectroscopy of anterior cingulate cortex in ADHD: Elevated choline signal correlates with slowed hit reaction times. J Psychiatr Res 2008; 42(7)587–595
  • Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci 2004; 16: 63–69
  • Dautry C, Vaufrey F, Broulliet E, Blizat N, Henry PG, Conde F, et al. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cerebral Blood Flow Metab 2000; 20: 789–799
  • Desmond JE, Gabrieli JD, Glover GH. Dissociation of frontal and cerebellar activity in a cognitive task: evidence for a distinction between selection and search. Neuroimage 1998; 7: 368–376
  • Fayed N, Modrego PJ. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol 2005; 12: 566–569
  • Fayed N, Modrego PJ, Castillo J, Davila J. Evidence of brain dysfunction in attention deficit-hyperactivity disorder: a controlled study with proton magnetic resonance spectroscopy. Acad Radiol 2007; 14: 1029–1035
  • Freeman JJ, Jenden DJ. The source of choline for acetylcholine synthesis in brain. Life Sci 1976; 19: 949–961
  • Geddes JW, Panchalingam K, Keller JN, Pettegrew JW. Elevated phosphocholine and phosphatidylcholine following rat entorhinal cortex lesions. Neurobiol Aging 1997; 18: 305–308
  • Golla H, Thier P, Haarmeier T. Disturbed overt but normal covert shifts of attention in adult cerebellar patients. Brain 2005; 128: 1525–1535
  • Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC. Magnetic resonance spectroscopy. J Neuroophthalmol 2005; 25: 217–226
  • Gurvitis GV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 1996; 40: 1091–1099
  • Hesslinger, B, Thiel, T, Tebartz, vE, Hennig, J, Ebert, D. 2001. Attention-deficit disorder in adults with or without hyperactivity: where is the difference? A study in humans using short echo (1)H-magnetic resonance spectroscopy. Neurosci Lett, 304:117–119.
  • Jin Z, Zang YF, Zeng YW, Zhang L, Wang YF. Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study. Neurosci Lett 2001; 315: 45–48
  • Kim BN, Lee JS, Cho SC, Lee DS. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med J 2001; 42: 19–29
  • Konrad K, Neufang S, Hanisch C, Fink GR, Herpertz-Dahlmann B. Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: Evidence from an event-related functional magnetic resonance imaging study. Biol Psychiatry 2006; 59: 643–651
  • Krause J, Dresel SH, Krause KH, La Fougere C, Zill P, Ackenheil M. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele. World J Biol Psychiatry 2006; 7: 152–157
  • Lenartowicz A, McIntosh AR. The role of anterior cingulate cortex in working memory is shaped by functional connectivity. J Cogn Neurosci 2005; 17: 1026–1042
  • MacMaster FP, Carrey N, Sparkes S, Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 2003; 53: 184–187
  • Mataro M, Garcia-Sanchez C, Junque C, Estevez-Gonzalez A, Pujol J. Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioural measures. Arch Neurol 1997; 54: 963–968
  • Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. The Journal of Neuropsychiatry and Clinical Neurosciences 1994; 6: 358–370
  • Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 2006; 163: 316–318
  • Natsume J, Watabane K, Tadokoro M, Negoro T, Aso K, Nakashima S, et al. Widespread glucose hypometabolism in patients with hippocampal atrophy: evaluation with f-fluorodeoxyglucose positron emission tomography. Journal of Epilepsy 1997; 10: 155–160
  • Nebel K, Wiese H, Stude P, de Greiff A, Diener HC, Keidel M. On the neural basis of focused and divided attention. Brain Res Cogn Brain Res 2005; 25: 760–776
  • Olbrich HM, Valerius G, Rusch N, Buchert M, Thiel T, Hennig J, et al. Frontolimbic glutamate alterations in first episode schizophrenia: Evidence from a magnetic resonance spectroscopy study. World J Biol Psychiatry 2008; 9(1)59–63
  • Perlov E, Philipsen A, Hesslinger B, Buechert M, Ahrendts J, Feige B, et al. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder – a magnet resonance spectroscopy study. J Psychiatr Res 2007; 41: 934–941
  • Perlov, E, Philipsen, A, Tebartz van Elst, L, Ebert, D, Henning, J, Maier, S, , et al. 2008. Hippocampus and amygdala morphology in adult attention-deficit/hyperactivity disorder. J Psychiatry Neurosci, in press.
  • Plessen KJ, Bansal R, Zhu H, Whiteman R, Amat J, Quackenbush GA, et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2006; 63: 795–807
  • Purdon AD, Rosenberger TA, Shetty HU, Rapoport SI. Energy consumption by phospholipid metabolism in mammalian brain. Neurochem Res 2002; 27: 1641–1647
  • Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001; 265: 54–84
  • Rusch N, Tebartz van Elst L, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, et al. A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage 2003; 20: 385–392
  • Russell VA, Oades RD, Tannock R, Killeen PR, Auerbach JG, Johansen EB, et al. Response variability in attention-deficit/hyperactivity disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2006; 2: 30
  • Scherk, H, Backens, M, Schneider-Axmann, T, Usher, J, Kemmer, C, Reith, W, , et al. 2007. Cortical neurochemistry in euthymic patients with bipolar I disorder. World J Biol Psychiatry. Sep, 2007; 13:1–10. [Epub ahead of print]
  • Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2004; 16: 367–378
  • Schweitzer JB, Faber TL, Grafton ST, Tune LE, Hoffman JM, Kilts CD. Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am J Psychiatry 2000; 157: 278–280
  • Schweitzer JB, Lee DO, Hanford RB, Zink CF, Ely TD, Tagamets MA, et al. Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatry 2004; 56: 597–606
  • Semrud-Clikeman M, Steingard RJ, Filipek P, Biederman J, Bekken K, Renshaw PF. Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 2000; 39: 477–484
  • Sergeant JA, Geurts H, Oosterlaan J. How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?. Behav Brain Res 2002; 130: 3–28
  • Sesack SR, Carr DB, Omelchenko N, Pinto A. Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann NY Acad Sci 2003; 1003: 36–52
  • Sparkes SJ, MacMaster FP, Carrey NC. Proton magnetic resonance spectroscopy and cognitive function in pediatric attention-deficit/hyperactive disorder. Brain Cogn 2004; 54: 173–175
  • Spencer TJ, Biederman J, Wilens TE, Faraone SV. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002; 63(Suppl 12)3–9
  • Stanley JA, Kipp H, Greisenegger E, MacMaster FP, Panchalingam K, Pettegrew JW, et al. Regionally specific alterations in membrane phospholipids in children with ADHD: An in vivo 31P spectroscopy study. Psychiatry Res 2006; 148: 217–221
  • Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005; 10: 900–919
  • Sun L, Jin Z, Zang YF, Zeng YW, Liu G, Li Y, et al. Differences between attention-deficit disorder with and without hyperactivity: a 1H-magnetic resonance spectroscopy study. Brain Dev 2005; 27: 340–344
  • Tebartz van Elst L. Amygdala morphometry in affective disorders. Am J Psychiatry 2005; 162: 629
  • Tebartz van Elst L, Thiel T, Hesslinger B, Lieb K, Bohus M, Hennig J, et al. Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. J Neuropsychiatry Clin Neurosci 2001; 13: 511–514
  • Tebartz van Elst L, Valerius G, Buchert M, Thiel T, Rusch N, Bubl E, et al. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 2005; 58: 724–730
  • Tebartz van Elst L, Ludaescher P, Thiel T, Büchert M, Hesslinger B, Lieb K, et al. Evidence of disturbed amygdala energy metabolism in patients with borderline personality disorder. Neurosci Lett 2007; 417: 36–41
  • Tebartz, vE, Woermann, FG, Lemieux, L, Trimble, MR. 1999. Amygdala enlargement in dysthymia – a volumetric study of patients with temporal lobe epilepsy. Biol Psychiatry, 46:1614–1623.
  • Tebartz, vE, Woermann, F, Lemieux, L, Trimble, MR. 2000. Increased amygdala volumes in female and depressed humans. A quantitative magnetic resonance imaging study. Neurosci Lett, 281:103–106.
  • Todd RD, Botteron KN. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome?. Biol Psychiatry 2001; 50: 151–158
  • Townsend J, Courchesne E, Covington J, Westerfield M, Harris NS, Lyden P, et al. Spatial attention deficits in patients with acquired or developmental cerebellar abnormality. J Neurosci 1999; 19: 5632–5643
  • Tzavara, ET, Li, DL, Moutsimilli, L, Bisogno, T, Di, MV, Phebus, LA, , et al. 2006. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol Psychiatry, 59:508–515.
  • Vance JE. Compartmentalization of phospholipids for lipoprotein assembly on the basis of molecular species and biosynthetic origin. Biochim Biophys Acta 1988; 963: 70–81
  • Yeo RA, Hill DE, Campbell RA, Vigil J, Petropoulos H, Hart B, et al. Proton magnetic resonance spectroscopy investigation of the right frontal lobe in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2003; 42: 303–310
  • Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993; 50: 333–340
  • Zetzsche T, Frodl T, Preuss UW, Schmitt G, Seifert D, Leinsinger G, et al. Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol Psychiatry 2006; 60: 302–310

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.